4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-18-043906
Options or other derivatives
- EVP, Head of R&D acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Seidel Ronald D. III EVP, Head of R&D | 2018-07-23 | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | D | ||
Loading xslF345X03/doc4.xml…